Literature DB >> 6321645

Neuromelanin and Parkinson's disease.

C D Marsden.   

Abstract

Neuromelanin is closely linked to Parkinson's disease, but is it the cause of the illness? The main pathology of Parkinson's disease is a loss of pigmented brain-stem neurones, and neuromelanin or its precursors might be cytotoxic. However, the cellular marker of Parkinsonian pathology, the Lewy body, is not confined to neurones containing neuromelanin. There are areas of the brain, of which the substantia innominata is a good example, which contain no neuromelanin or catecholaminergic neurones, but whose cells are packed with Lewy bodies and die. It is concluded that it is not neuromelanin, but the Lewy body which holds the key to Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6321645

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  25 in total

Review 1.  Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.

Authors:  F Tribl; K Marcus; G Bringmann; H E Meyer; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

2.  The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.

Authors:  Erin K Butler; Aaron Voigt; A Kathrin Lutz; Jane P Toegel; Ellen Gerhardt; Peter Karsten; Björn Falkenburger; Andrea Reinartz; Konstanze F Winklhofer; Jörg B Schulz
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

3.  A lysosomal lair for a pathogenic protein pair.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Sci Transl Med       Date:  2011-07-13       Impact factor: 17.956

Review 4.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

5.  The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study.

Authors:  K G Baker; I Törk; J P Hornung; P Halasz
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 6.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

7.  2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin.

Authors:  P A Rosenberg; R Loring; Y Xie; V Zaleskas; E Aizenman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 8.  Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.

Authors:  E C Hirsch
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

9.  Model neuromelanins as antioxidative agents during lipid peroxidation.

Authors:  T Wilczok; K Stepien; A Dzierzega-Lecznar; A Zajdel; A Wilczok
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

Review 10.  The roles of non-coding RNAs in Parkinson's disease.

Authors:  Maryam Majidinia; Aynaz Mihanfar; Reza Rahbarghazi; Alireza Nourazarian; BakiyeGoker Bagca; Çığır Biray Avci
Journal:  Mol Biol Rep       Date:  2016-08-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.